Tauns Laboratories, Inc. (JP:197A) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
TAUNS Laboratories, Inc. has signed a Memorandum of Understanding with Roche Diagnostics K.K. to enter into a Master Transaction Agreement for the sale of TAUNS’ products, aiming to enhance business growth for both companies. The agreement will cover specific diagnostic products and is set to commence in January 2025.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.